Author = Zahra Hajimahdi
Number of Articles: 14
1. Design, Synthesis, Docking Study and Biological Evaluation of 4-Hydroxy-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide Derivatives as Anti-HIV Agents

Volume 20, Issue 3, Summer 2021, Pages 1-12

Ali Imani; Sepehr Soleymani; Rouhollah Vahabpour; Zahra Hajimahdi; Afshin Zarghi

2. HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies

Volume 20, Issue 2, Spring 2021, Pages 333-369

Mohammad Mahboubi-Rabbani; Zahra Hajimahdi; Maryam Abbasi; Afshin Zarghi

3. 4-(1-Benzyl-1H-benzo[d]imidazol-2-yl)-4-oxo-2-butenoic Acid Derivatives: Design, Synthesis and Anti-HIV-1 Activity

Volume 20, Issue 1, Winter 2021, Pages 408-417

Nafiseh Karimi; Rouhollah Vahabpour Rodsari; Mahsa Azami Movahed; Zahra Hajimahdi; Afshin Zarghi

4. Design, Synthesis, Molecular Modeling Studies and Biological Evaluation of N'-Arylidene-6-(benzyloxy)-4-oxo-1,4-dihydroquinoline-3-carbohydrazide Derivatives as Novel Anti-HCV Agents

Volume 18, Issue 4, Autumn 2019, Pages 1790-1802

Seyyed Mohammad Ismaeil MahboobiRabbani; Roholah Vahabpour Rodsari; Zahra Hajimahdi; Afshin Zarghi

5. Design, Synthesis, Molecular Modeling Study and Biological Evaluation of New N'-arylidene-pyrido[2,3-d]pyrimidine-5-carbohydrazide Derivatives as Anti-HIV-1 Agents

Volume 18, Special Issue, Autumn 2019, Pages 237-248

Elnaz Ebrahimzadeh; Sayyed Abbas Tabatabai; Roholah Vahabpour Rodsari; Zahra Hajimahdi; Afshin Zarghi

6. Molecular Docking and QSAR Study of 2-Benzoxazolinone, Quinazoline and Diazocoumarin Derivatives as Anti-HIV-1 Agents

Volume 18, Issue 3, Summer 2019, Pages 1253-1263

Kamyar Faghihi; Mahdieh Safakish; Tannaz Zebardast; Zahra Hajimahdi; Afshin Zarghi

7. Design, Synthesis, Molecular Modeling, In Silico ADME Studies and Anti-HIV-1 Assay of New Diazocoumarin Derivatives

Volume 17, Special Issue 2, Autumn 2018, Pages 65-77

Zeynab Alimi Livani; Mahdieh Safakish; Zahra Hajimahdi; Sepehr Soleymani; Rezvan Zabihollahi; Mohammad Reza Aghasadeghi; Eskandar Alipour; Afshin Zarghi

8. QSAR Modeling of COX-2 Inhibitory Activity of Some Dihydropyridine and Hydroquinoline Derivatives Using Multiple Linear Regression (MLR) Method

Volume 16, Issue 2, Spring 2017, Pages 525-532

Somaye Akbari; Tannaz Zebardast; Afshin Zarghi; Zahra Hajimahdi

9. Progress in HIV-1 integrase inhibitors: A review of their chemical structure diversity

Volume 15, Issue 4, Autumn 2016, Pages 595-628

Afshin Zarghi; Zahra Hajimahdi

10. QSAR Analysis for Some 1, 2-Benzisothiazol-3-one Derivatives as Caspase-3 Inhibitors by Stepwise MLR Method

Volume 15, Issue 2, Spring 2016, Pages 439-448

Zahra Hajimahdi; Fatemeh Safizadeh; Afshin Zarghi

11. Small Molecules as Protein-ProteinInteraction Inhibitors

Volume 15, Special Issue, Winter 2016

Zahra Hajimahdi

12. Design, Synthesis and Biological Evaluation of new 1,4-Dihydropyridine (DHP) Derivatives as Selective Cyclooxygenase-2 Inhibitors

Volume 14, Issue 4, Autumn 2015, Pages 1087-1093

Afshin Zarghi; Iman Sabakhi; Vigen Topuzyan; Zahra Hajimahdi; Bahram Daraei; Hadi Arefi

14. Design, Synthesis and Biological Evaluation of 5-Oxo-1,4,5,6,7,8 Hexahydroquinoline Derivatives as Selective Cyclooxygenase-2 Inhibitors

Volume 13, Supplement, Winter 2014, Pages 61-69

Afshin Zarghi; Iman Sabakhi; Vigen Topuzyan; Zahra Hajimahdi; Bahram Daraie

Iranian Journal of Pharmaceutical Research

Journal Archive